FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to virology, and concerns the Newcastle disease virus strain. The characterised strain NDV/Mallard/Adigeya/8/2008 is recovered from a dead duck, and deposited in the Collection of Cultures of the State Research Centre for Virology and Biotechnology "Vector" under registration number No. V-512.
EFFECT: presented strain may be used to study the oncolytic properties and mechanisms, and to develop the anticancer candidate preparations based thereon.
9 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEWCASTLE DISEASE VIRUS STRAIN USED IN SERUM DIAGNOSIS OF NEWCASTLE DISEASE IN HEMAGGLUTINATION INHIBITION TEST | 2010 |
|
RU2482184C2 |
| NEWCASTLE DISEASE VIRUS STRAIN FOR STUDYING ONCOLYTIC PROPERTIES AND MECHANISMS OF ONCOLYSIS TO CREATE PROTOTYPE ANTICANCER PREPARATION | 2014 |
|
RU2562115C1 |
| NEWCASTLE DISEASE NDVH-2 VIRUS STRAIN FOR STUDY OF POSSIBILITY OF VIRAL ONCOLYTIC PREPARATION DEVELOPMENT ON ITS BASIS | 2016 |
|
RU2644676C1 |
| STRAIN OF INFLUENZA VIRUS OF SUBTYPE A/pochard/Siberia/249/08-MA H10N7 FOR OBTAINING ANTIGEN-CONTAINING DIAGNOSTIC PREPARATION AND DIAGNOSTIC POLYCLONAL SERUM, APPLICATION AS CONTROL REFERENCE-SAMPLE IN EVALUATING SPECIFICITY OF TEST SYSTEMS BASED ON PCR AND FOR STUDY OF ANTIVIRAL PREPARATIONS in vitro AND in vivo | 2013 |
|
RU2522813C1 |
| SUBTYPE H1N1 INFLUENZA VIRUS STRAIN A/RUSSIA/OL/2009-MA FOR STUDY OF THERAPEUTIC AND PREVENTIVE ACTIVITY OF ANTIVIRAL PREPARATIONS in vitro AND in vivo | 2010 |
|
RU2451072C1 |
| NEWCASTLE DISEASE VIRUS "VNIIZZH G7" STRAIN FOR PRODUCTION OF BIOPREPARATIONS FOR DIAGNOSIS AND SPECIFIC PREVENTION OF NEWCASTLE DISEASE OF BIRDS | 2024 |
|
RU2821028C1 |
| SET OF OLIGONUCLEOTIDE PRIMERS FOR PRIMARY STRUCTURE F NEWCASTLE DISEASE VIRUS GENE CLASS I | 2015 |
|
RU2590718C1 |
| METHOD OF TREATING ONCOLOGICAL DISEASES | 2008 |
|
RU2379055C1 |
| STRAIN OF BIRD FLU VIRUS OF A/common gull/Chany/2006 H5N1 SUBTYPE FOR PREPARATION OF ANTIGEN-CONTAINING DIAGNOSTIC OR VACCINE MEDICATION | 2009 |
|
RU2400536C1 |
| THERAPEUTIC COMPOSITIONS AND METHODS OF USING FOR TREATING CANCER | 2016 |
|
RU2720984C2 |
